Products of microbial metabolism can activate AhR and upregulate IL-22 production, leading to increased AMP and mucin production in IECs which in turn contribute to reduced colitis susceptibility and may shape microbiome composition and function [6]. This evidence concerns the gene IL22 and colitis.